1996
DOI: 10.1016/0003-4975(96)00755-2
|View full text |Cite
|
Sign up to set email alerts
|

Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
26
0
2

Year Published

1998
1998
2011
2011

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(31 citation statements)
references
References 17 publications
3
26
0
2
Order By: Relevance
“…In the present series of patients this advantage was observed during CPB, and IT was not the case considering the intra-operative as a whole, and in the early postoperative period. Patients undergoing cardiac operations who will require transfusions can be predicted before the operation by a number of variables, including red blood cell mass [11]. This is consistent with the assumption that patients with a low red cell mass are more likely to have low hematocrit values and therefore require transfusions after CPB as a result of the proportionately greater hemodilution caused by CPB in these patients.…”
Section: Discussionsupporting
confidence: 58%
“…In the present series of patients this advantage was observed during CPB, and IT was not the case considering the intra-operative as a whole, and in the early postoperative period. Patients undergoing cardiac operations who will require transfusions can be predicted before the operation by a number of variables, including red blood cell mass [11]. This is consistent with the assumption that patients with a low red cell mass are more likely to have low hematocrit values and therefore require transfusions after CPB as a result of the proportionately greater hemodilution caused by CPB in these patients.…”
Section: Discussionsupporting
confidence: 58%
“…Several possible methods of reducing blood loss and the need for ABT associated with spinal fusion surgery currently exist. These include use of autologous pre-donation of blood [7,11,16,26, 31, 32, 40], blood dilution techniques [4,10,14,15,19,22], erythropoietin [24], use of antifibrinolytics [1,8,9,20,24,27, 30, 34, 35, 41], and use of cell salvage [6, 33]. Prior research on techniques used to reduce the need for ABT has previously been conducted in single-site hospitals or in a small number of patients enrolled in a clinical trial, which does not accurately provide a clear picture of the utilization and cost burden associated with it.…”
Section: Introductionmentioning
confidence: 99%
“…2000 mL of whole blood was removed based on a previously derived formula using the patient's initial hematocrit, the target hematocrit prior to bypass, the CPB pump's prime volume, and the patients estimated blood volume to reach a target hematocrit on bypass of 18%. 1 Euvolemia was maintained using a combination of 2 L of Hextend® (Abbott Laboratories, North Chicago, IL, USA) and 1.3 L of Plasma-Lyte® (Baxter Healthcare Corporation, Deerfield, IL, USA). The patient's mean arterial blood pressure was maintained within 20% to 30% of baseline values.…”
Section: éLéments Cliniques : Un Homme De 47 Ans Témoin De Jéhovah mentioning
confidence: 99%